Synsory Bio Analysis
What is Synsory Bio?
Synsory Bio develops advanced protein therapeutics that target diseased tissues, enhancing the efficacy of potent drugs for cancer and autoimmune disorders.
Employees
2
Founded
2023
Company Stage
Seed
Investors
- Y Combinator
YC Batch
W24
Product Features & Capabilities
- next-generation protein therapeutics, synthetic sensing functions, conditional activation upon sensing disease markers, targeted activation at diseased tissue, potential applications in cancer and autoimmune disorders
Who are the founders of Synsory Bio
ET
Elliot Tague
Founder
NT
Nathan Tague
Founder
Market Focus
Synsory Bio primarily focuses on the biotechnology industry, specifically in developing next-generation protein therapeutics for conditions like cancer and autoimmune disorders.
Competitors Overview
Synsory Bio operates in the protein therapeutics market, focusing on next-generation therapies that activate specifically at diseased tissues. Its main competitors include:
- InduPro: This company is advancing proximity-based protein therapeutics for cancer and autoimmune diseases. They recent
See something that needs updating? Suggest edits to this profile.